SCHEMBL9968585

SCHEMBL9968585

O=S(=O)(NCc1ccc(O)c(O)c1)c1ccc(OC(F)(F)F)c(Br)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.50
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
CYP19A1 P11511 2/20 0.41
ALDH1A1 P00352 1/20 0.40
CA1 P00915 3/20 0.40
CA2 P00918 3/20 0.40
CA9 Q16790 3/20 0.40
NAMPT P43490 2/20 0.39
KMT2A Q03164 1/20 0.39
MMP1 P03956 1/20 0.39
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
MMP14 P50281 1/20 0.39
ADAM17 P78536 1/20 0.39
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CA12 O43570 2/20 0.38
CA4 P22748 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9968024 0.85 SLC6A2 (0.45) PKMSLC6A2SLC6A4SLC6A3CYP19A1
SCHEMBL9968023 0.84 SLC6A2 (0.41) PKMSLC6A2SLC6A4SLC6A3CYP19A1
SCHEMBL9968581 0.84 KDM4E (0.43) SLC6A2SLC6A4SLC6A3CYP19A1ALDH1A1
SCHEMBL9968571 0.84 SLC22A12 (0.43) SLC6A2SLC6A4SLC6A3CYP19A1NAMPT
SCHEMBL9968569 0.82 MAPK1 (0.44) PKMSLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL9941878 0.81 MAPT (0.61) PKMALDH1A1KMT2AHTT
SCHEMBL9941726 0.72 TSHR (0.61) PKMALDH1A1KMT2AHTT
SCHEMBL26536708 0.71 ALDH1A1 (0.52) ALDH1A1CA1CA2CA9KMT2A
SCHEMBL15682729 0.71 MEP1B (0.55) CYP19A1ALDH1A1CA1CA2CA9
SCHEMBL29087314 0.69 SMN1; SMN2 (0.59) SLC6A2SLC6A4SLC6A3CYP19A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012082862-A2 ANDROGEN RECEPTOR INHIBITORS AND METHODS OF USE THEREOF BETH ISRAEL DEACONESS MEDICAL CENTER (US) 2012-06-21 WO disclosed